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Abstract
Purpose The response to traumatic brain injury (TBI) is com-
plex and induces various biological pathways in all brain
regions that contribute to bad outcomes. The cerebellar hyp-
oxia after a frontal cortex injury may potentiate the pathophys-
iological impacts of TBI. Therefore, a gene expression analysis
was conducted to determine the influence of hypoxia on TBIs.
Material and methods Total RNA, including microRNAs,
was isolated from the cerebellum of individuals who had died
from severe frontal cortex injuries or due to natural causes of
death (reference group).
Results From a total of 19,596 genes, an average of 59.56 %
messenger RNAs (mRNAs) appeared expressed with 42 of
them showing significant >2-fold differences of upregulated
(n=18) and downregulated (n=24) genes. The validity of 14
candidate genes (with low p values and high fold differences
or based on cited literature) was confirmed using qRT-PCR
(Spearman correlation r2=0.93). Only four genes appeared to
be either upregulated (FOSB and IL6) or downregulated
(HSD11B1 and HSPA12B). From a total of 667 microRNAs,
altogether, 248 microRNAs appeared expressed with 13 of
them showing significant differences in the mean gene
expression. The combination of two mRNAs (HSPA12B/
FOSB or IL6/HSD11B1) or two microRNAs (either miR-
138/miR-744 or miR-195/miR-324-5p) completely discrim-
inated both groups, a finding unaltered by potential con-
founders such as age at biosampling, survival time, and
the postmortem interval.
Conclusions Cerebellar hypoxia markers are important to
understand the pathophysiology of TBIs and could be used
for therapeutic strategies or forensic purposes, e.g., to assess
the severity of a brain injury.
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Introduction
Traumatic brain injury (TBI) is among the most frequent
causes of death after traffic accidents or assaults [1, 2].
The primary impact can promote secondary damages with
the extent depending upon injury severity. Secondary events
can lead to cerebral hypoxia that induces the anaerobic gly-
colysis pathway resulting in energy depletion. This promotes
the neurotoxic cascade like the energy-dependent ion pumps
failure, acidosis, membrane depolarization, the influx of cal-
cium and sodium, the release of glutamate, and the activation
of apoptosis and inflammation [3–8]. The secondary events
compromise a not well-understood multi-cellular system in-
volving hundreds of interacting components.
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Gene expression profiling has the capability to identify
pathways and novel biomarkers which are associated with
cerebral hypoxia following TBI.
It is known that small RNAs, named microRNA (miRNA),
are involved in the regulation of gene expression after TBI
[9–13]. So far, about 940 different miRNA species have been
detected in humans [14, 15]. Prominent features of miRNAs
are the tissue specificity and disease-specific patterns [16, 17].
However, studies on human postmortem whole-genome tran-
scriptional changes (mRNAs) and post-transcriptional
miRNA gene expression changes that are associated with
cerebral hypoxia, especially in the cerebellum, are missing.
The cerebellum was chosen because it reacts vulner-
ably to hypoxia [18, 19] and could contribute to the
TBI pathophysiology.
Neurological deficits in the cortex following TBI are cor-
related with a loss of motor control and coordination; these
properties are associated with cerebellar functions [20]. It
could be shown that a forebrain injury resulted in a loss of
Purkinje cells in the cerebellum [21]. It was supposed that the
excitotoxic release of glutamate is involved in the Purkinje
cell death following a forebrain injury [22]. However, the
causes of indirect cerebellar damages in areas that are distant
from the injured site are not completely understood.
The main question was if it would be possible to find
biomarkers for the identification of hypoxia in the cerebellum
after a frontal a cortex injury (violent death) in comparison to
the reference group (natural death) based on gene expression
changes considering potential confounders such as age at
biosampling, survival time (used as a surrogate for the severity
of the cranial trauma), and the postmortem interval time (time
interval between the person’s death and the tissue sampling).
Material and methods
Autopsy cases
We used small brain sections from deceased humans that were
taken during the medicolegal investigation of the deceased.
The Leipzig public prosecutor’s office allowed us to analyze
these samples to determine the cause of death according to the
guidelines from the central ethics commission of the German
Medical Association. Following the prerequisites of the ethics
commission (e.g., use of anonymized samples, no ethically
questionable study, and no evidences for rejection from the
deceased), our study became approved in 2012 by the local
ethics commission of the Medical Faculty of the Leipzig
University (AZ: 117-12-23012012).
We included male Caucasians aged between 19 and
80 years (median TBI, 50 years; reference group, 57 years).
The causes of injury in the TBI group (n=8) were one fall, two
household accidents, and five motor vehicle accidents. The
TBI group comprised individuals with a frontal cortical con-
tusion zone and cranial traumata as the cause of death. The
survival time in the TBI group varied between <2 and 18 h
(mean, 4 h).
In the reference group (n=7), there were no brain
contusions and death had occurred within less than 2 h
because of other reasons, namely myocardial infarction,
ischemic heart disease, pulmonary embolism, ruptured
aneurysm, or pneumonia.
The postmortem interval in both groups varied between 29
and 132 h (median, 58 h).
We excluded individuals due to toxicological reasons (drug
and alcohol consumption), histological damages to the brain
(cerebellum contusion in the cranial trauma group andmedical
history of cranial trauma in the reference group), or known
genetic and neurological diseases. None of the cases showed
any signs of neoplasm (for details see Table 1).
Tissue samples and histological examination
Samples of prepared semisterile cerebellar tissue were taken
after death, cryopreserved in nitric oxide, and stored at −80 °C
before use. All tissue samples were examined by an experi-
enced pathologist for histological classification. For that rea-
son, the tissue sections were stained using hematoxylin and
eosin to evaluate the morphology and possible traumatic
changes. None of the TBI cases showed any traumatic dam-
ages such as bleedings or tissue lacerations, cerebellar
edemata (loosening of Bergmann-Glia, spongiotic swelling,
and pericellular edema), or necrotic areas. Furthermore, no
relevant histomorphological differences between the TBI and
control cases were found.
RNA isolation
Frozen biopsy pieces were incubated into 2 ml ceramic
bead tubes (1.4 mm; Süd-Laborbedarf GmbH, Gauting,
Germany) filled with 700 μl QIAzol® Lysis Reagent
(Qiagen, Hilden, Germany), carefully thawed, and ho-
mogenized (PowerLyzerTM24, Süd-Laborbedarf GmbH,
Gauting, Germany). Total RNA, including small RNAs, was
isolated (miRNeasy Mini Kit (Qiagen, Hilden, Germany) and
the remaining DNAwas digested. RNAwas stored at −80 °C
until its use. Quality and quantity of isolated total RNAwere
measured spectrophotometrically (NanoDrop, PeqLab Bio-
technology, Erlangen, Germany) while the RNA integrity
number (RIN) was assessed by the 2100 Agilent Bioanalyzer
(Life Science Group, Penzberg, Germany). Aliquots of sam-
ples with suspicious RIN 6.0–7.0 (n=6) were incubated for
1 h at 37 °C to test for the presence of RNases. The RNA
integrity (28/18S ribosomal RNA (rRNA) bands) was verified
by agarose gel electrophoresis. All analyzed samples showed
unaltered 28/18S bands without any signs of degradation
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(smear) and were forwarded for both whole-genome microar-
ray analysis and qRT-PCR. All samples passed the multiple
quality controls inherent to both methods.
Whole-genome microarray and data analysis
Genome-wide gene expression profiling was carried out using
the Agilent oligo microarray GE 8x60K v2 (Agilent Technol-
ogies, Waldbronn, Germany) combined with a one color-
based hybridization protocol. Signals on the microarray were
detected using the Agilent DNA Microarray Scanner.
GeneSpring GX12.5 software was employed to quantile nor-
malize the raw data. We analyzed gene expression as an
outcome and compared gene expression between both groups
using the non-parametric Welch’s approximate t test. Genes
had to be expressed in at least 50 % of the samples per group.
Only significant and ≥2-fold differences in gene expression
among groups were considered for comparisons, and unad-
justed p values and p values adjusted for multiple comparisons
(false discovery rate) were calculated. All gene candidates
underwent gene set enrichment analyses using PANTHER
pathway software (http://www.pantherdb.org/) that groups
genes with similar biological functions based on their
annotation. For methodological validation purposes, we
selected 14 genes showing low p values and high fold
changes (n=10) or TBI markers based on cited literature
(n=4). These genes were examined on the same samples but
using qRT-PCR which provides quantitative data. These data
were finally compared with semi-quantitative whole-genome
microarray data for methodological comparison purposes and
analyzed employing the logistic regression analysis.
Quantitative RT-PCR experiments
We employed TaqMan chemistry (Hs-code in parenthesis) for
the detection of our ten mRNA gene candidates which are
ARPC5 (hs00271722_m1), BCAT1 (Hs00398962_m1),
FOSB (Hs00171851_m1), GADD45B (Hs00169587_m1),
GRIA3 (Hs01557466_1), HSD11B1 (Hs01547870_m1),
HSPA12B (Hs00369554_m1), IL6 (Hs00985639_m1),
PRPH (Hs00196608_m1), and RGS6 (Hs00188763_m1).
Based on cited work [23], we added another four markers
to our analysis which are CASP3 (Hs00234387_m1), GFAP
(Hs00909233_m1), NTRK2 (Hs00178811_m1), and S100B
(Hs00902901_m1). The RNA samples were processed by
converting 5 μg of total RNA into cDNA (High Capacity
Kit) and running a PCR protocol according manufacturer’s
instructions (Life Technologies GmbH, Darmstadt, Germany)
For all transcripts, we tested 18S rRNA (Hs03928985_g1),
GAPDH (Hs99999905_m1), and HBMS (Hs00609297_m1)
for normalization purposes.
Altogether, 667 miRNA could be analyzed employing two
384-well LDAs (LDA type A&B). Per LDA type, a 2-μg
RNA aliquot of each RNA sample was analyzed according
manufacture instructions (Life Technologies GmbH, Darm-
stadt, Germany).
All technical procedures for qRT-PCR were performed in
accordance with standard operating procedures implemented
in our laboratory in 2008 when the Bundeswehr Institute of
Radiobiology became accredited according to DIN EN ISO
9001/2008. Ahead of our experiment, we had established the
upper limit of the linear-dynamic range of our qRT-PCR using
replicate measurements on one of our miRNA samples. The
upper limit occurred at Ct ≤26 (cycle threshold, Ct). Ct values
Table 1 Details of trauma and
control cases Age Cause of injury Cause of death Survival
time (h)
PMI (h)
Trauma cases 50 Fall Brain injury <2 48
58 Household accident Brain injury <2 87
19 Motor vehicle accident Brain injury + multiple injuries <2 60
19 Motor vehicle accident Brain injury <2 29
49 Motor vehicle accident Brain injury + multiple injuries <2 64
49 Motor vehicle accident Brain injury 3 50
74 Motor vehicle accident Brain injury 8 113
80 Household accident Brain injury 18 132
Control cases 57 Collapsed suddenly Myocardial infarction <2 95
47 Collapsed suddenly Ruptured aneurysm <2 47
44 Collapsed suddenly Ischemic heart disease <2 52
51 Collapsed suddenly Myocardial infarction <2 63
71 Pulmonary embolism Ischemic heart disease <2 67
68 Collapsed suddenly Myocardial infarction <2 43
75 Collapsed suddenly Pneumonia <2 43
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were normalized relative to the median gene expression of the
examined miRNAs. This approach to normalization was more
robust compared to the use of the internal control (data not
shown).
Statistical analysis of quantitative RT-PCR mRNA
and miRNA data
Normalized Ct values of our miRNA and mRNA candidate
genes must be expressed in at least 50 % of the samples in one
group. We compared the TBI group and the control group by
examining statistical differences using either the t test or the
Mann–Whitney rank sum test where appropriate. Significant
candidate genes were finally examined using the logistic
regression analysis. By means of the logistic regression anal-
ysis, a prediction model and a weighting factor (maximum
likelihood estimate) were calculated for each parameter so that
the contrast between both groups became amplified. Predic-
tions of this model were compared with the known group
members, and concordant pairs of predicted probabilities
and observed responses were computed using the Hosmer-
Lemeshow goodness-of-fit test. Concordances of 100 % indi-
cated a complete agreement of the model with the known
groups and, therefore, a complete discrimination of TBI from
the reference group.
These analyses were run separately for each single miRNA
and our selected 14mRNAcandidate genes (univariate analysis).
Finally, we conducted amultivariate analysis to examinewhether
a combination of variablesmight improve our results, employing
forward and backward selection procedures. This was done for
complete data sets only and, separately, for the miRNA and
mRNA genes to be able to better examine potential candidates
originating from the transcriptional or post-transcriptional level.
In a final step, we separately adjusted our logistic regression
models for each of three potential confounders (age at
biosampling, survival time, and the postmortem interval). At
first, we examined the impact of the confounder on the discrim-
ination of our groups (cranial trauma group versus controls). In
a second step, we adjusted confounders (continuous scale) to
models comprising significant associations of the groups with
our candidate genes (univariate and multivariate). None of the
confounders contributed significantly to these models and they
were hence excluded from further analysis (data not shown).
Results
RNA isolation
On average, we isolated 33.6 μg of total RNA (SD ±14.11;
range, 8.65–62.22) from 10 to 20 mg of our biopsy samples.
The average RIN was 7.4 (SD ±0.92; range, 6.0–9.1).
Whole-genome microarray and PANTHER classification
From 19,596 gene mRNAs (42,545 transcripts) spotted on the
whole-genome microarray, on average, 59.56 % (SD ±2.32;
range, 55.0–63.5%) was distinguishable from the background
(expressed). The number of significant and differentially
expressed genes (with an uncorrected p value of <0.05 and a
2-fold gene expression difference) was 42 with about half of
them being either upregulated (18) or downregulated (24).
None of these genes could sustain multiple comparisons.
Due to the low number of differentially expressed genes
(at least 100 genes are needed), we could not run a
PANTHER enrichment analysis of biological processes
such as molecular functions, cellular components, protein
classes, and pathways.
Validation of whole-genome microarray results using
qRT-PCR
The genome microarray results were validated with qRT-PCR
using 14 selected genes (Fig. 1). A linear regression was
calculated over all genes except for one outlier (ARPC5).
Both methods were closely correlated (r2=0.93).
For qRT-PCR, we tested 18S rRNA, GAPDH, and HBMS
for normalization purposes. All three markers were constantly
expressed in TBI and control samples, but the 18S rRNA
proved to be the most reliable among them. For instance, the
main Ct values (±SD) referring to all brain samples were
20.38±0.72 for 18S rRNA, 28.61±0.56 for HBMS, and
21.13±0.73 for GAPDH.
Fig. 1 Expression of 14 differentially expressed genes (ARPC5, BCAT,
CASP3, FOSB, GFAP, GADD45B, GRIA3, HSD11B1, HSPA12B, IL6,
NTRK2, PRPH, RGS6, and S100B) in the cerebellum following a frontal
cortex injury. bar refer to the mean values and error bar indicate the
standard deviation of gene expression. Data are represented as fold
change in gene expression relative to the controls
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Quantitative mRNA and miRNA data
The 14 mRNAs had a relative low SD (0.26 to 2.53). The
sensitivity, specificity, positive and negative predictive values
(PPV/NPV) as well as concordance ranged from 42.9 to
100 % (sensitivity/specificity), from 60.0 to 100 % (PPV/
NPV), and from 60.7 to 96.4 % (concordance), respectively
(Online Resource 1, supplemental table 1).
Ten of our genes showed control values and four genes
appeared either upregulated (FOSB and IL6) or downregulat-
ed (HSD11B1 and HSPA12B). These four genes remained
significantly (p<0.1) associated with the two groups in the
logistic regression analysis.
The combinations of two mRNAs, namely HSPA12B/
FOSB and IL6/HSD11B1, completely discriminated TBI
from the reference group.
From 667 miRNAs assayed, the qRT-PCR data were avail-
able for 248 miRNAs being expressed. Among them, 13
miRNAs showed a significant difference in mean gene ex-
pression per group and high consistency of data expressed by
a low SD (0.10 to 0.53). We calculated the sensitivity, speci-
ficity, PPV, NPV, and concordance.
The values ranged from 57.1 to 100 % (sensitivity/speci-
ficity), from 66.7 to 100 % (PPV), from 72.7 to 100 % (NPV),
and from 80.4 to 90.6 % (concordance), respectively (Online
Resource 1, supplemental table 1).
The same genes were examined separately using the logis-
tic regression analysis. p values became significant (p<0.01).
We then combined significant miRNAs to better discriminate
both groups. Combinations of two miRNAs, namely miR-
138/miR-744 and miR-195/miR-324-5p, completely dis-
criminated both groups. Since we restricted this analysis
to complete data sets, we loosed four genes with missing
gene expression data either in the TBI group (miR-370),
the reference group (miR-16), or both groups (miR-504,
miR-320B).
Discussion
The present study is the first of its kind in assessing hypoxia in
the cerebellum following a frontal cortex injury in postmortem
human brain tissue via a gene expression analysis.
The reversibility of secondary damages like hypoxia offers
a chance for therapy to reduce cellular damage and improve a
functional recovery. A prerequisite for the development of
therapy strategies is the identification of the gene expression
network. The study was focused on the cerebellum because of
its vulnerability to hypoxia [18, 19]. Some evidence suggests
that a cerebellum dysfunction after a forebrain injury contrib-
utes to TBI neuropathology [20, 21]. Park and colleagues
showed a loss of Purkinje cells in the cerebellum following
forebrain injuries [21]; possibly, it is the excitotoxic release of
glutamate that promotes the Purkinje cell death [22].
Most human TBI studies focused their attention on protein
changes in close proximity to the injury site, e.g., in the cortex,
the ipsilateral cortex, the pericontusional zone, the hippocam-
pus, or the traumatized cerebellum [23–29]. These studies
detected an elevation of apoptosis [24–26, 29], stress response
[28], inflammation [27], and cell cycle control [28] in the TBI
group compared with the controls.
However, only few studies investigated transcriptional
changes (mRNAs) of the human brain following TBI [23,
27, 30]. Frugier and colleagues found that IL-6, TNF-α,
GM-CSF, and IFN-γ protein concentrations are already in-
creased a few minutes following a TBI, indicating the impor-
tant role in the early phase of an inflammatory cascade. The
rise of the protein level of these pro-inflammatory cytokines
correlates with increased mRNA levels [27].
This is in concordance with our results where a 6-fold IL-6
mRNA upregulation was detected in the cerebellum. Interest-
ingly, Arand and colleagues found that IL-6 plasma levels
were 8-fold higher in cases of death than those of surviving
patients [31]. Furthermore, the severity of trauma correlated
with the elevation of IL-6 expression [32].
Staffa and colleagues investigated apoptosis (CASP3) as
well as cell cycle control (S100B), neuronal cell growth
(NTRK2), and intermediate filament (GFAP) mRNAmarkers
in traumatized cerebellum [23]. We could not detect any
significant changes of these four markers in the TBI group
in comparison to our reference group. Possibly, these four
markers indicated a direct trauma.
Frugier and colleagues as well as Staffa and colleagues
used predefined markers (top–down study) [23, 27]. In con-
trast, we andMichael and colleagues [30] did a whole-genome
analysis (bottom–up study) of human brain tissues. Michael
and colleagues found that transcription factors (c-FOS, JunB,
and Zif268) and the heat shock protein Hsp70 were upregu-
lated in the pericontusional zone of TBI patients [30].
Dave and colleagues also detected a c-fos mRNA upregu-
lation in injured cerebellum. Interestingly, hypoxia potentiated
the c-fos mRNA in the cerebellum [18]. It must be mentioned
that hypoxia alone had no effect on c-fos mRNA levels, but
the highest increase of c-fos was in the TBI group followed by
hypoxia. This marker can be used to discriminate between
hypoxia alone and hypoxia followed by a TBI. Different
studies have shown that pathophysiological changes wors-
ened when a TBI was accompanied by hypoxia [33–36].
In our study, the transcription regulator (FOSB), a member
of the FOS family like c-fos, was significantly upregulated in
the cerebellum despite its distance from the injured site. Fur-
thermore, FOSB showed a direct miRNA relationship (down-
regulated miR-370 and upregulated FOSB; see Online Re-
source 1, supplemental table 2). It is known that the FosB/
JunD AP-1 transcription factor complex is involved in
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glutamate-mediated excitotoxicity [37]. This could promote
the loss of Purkinje cells in the cerebellum [22]. The FOSB
marker could probably be used to detect a TBI-induced hyp-
oxia just like the c-fos marker.
Furthermore, the increase of pro-inflammatory cytokines
like IL-6 could also contribute to cell death in the cerebellum.
We suppose that, on the one hand, cell death is promoted
through the release of glutamate and cytokines like IL-6, but
on the other hand, cell survival is promoted by preventing
apoptosis through significant downregulation of HSPA12B
(heat shock 70kD protein 12B; see Fig. 1). It could be shown
that a downregulation of HSPA12B inhibited the expression
of active caspase-3 [38]. In our study, the caspase 3 was
slightly downregulated but showed a direct miRNA relation-
ship (upregulated let-7a and downregulated caspase 3; see
Online Resource 1, supplemental table 2).
Our results also showed a significant downregulation of the
steroid biosynthesis marker (HSD11B1) in the TBI group in
comparison to the reference group. This could contribute to an
improvement of cognitive functions [39].
We assume that, despite the promotion of cell survival
mechanisms, the detrimental effects are predominant in the
cerebellum.
So far, only one study has analyzed post-transcriptional
changes (miRNA species) in blood plasma samples from
patients surviving TBI (the age varied between 14 and
65 years) [12]. In this study, miR-16 and miR-92a were used
as specific markers to distinguish TBI from a polytrauma as
well as a mild brain trauma from a severe brain trauma. Both
markers appeared significantly reduced in the TBI group
suffering from severe trauma, which is in agreement with a
significant downregulation of miR-16 we had observed in the
cerebellum of deceased persons after fatal TBI.
Recently, authors pointed to limitations in the quality of
RNA isolated from postmortem human brain tissue [40].
Mean RIN values of 2.8 (ranging from 1.0 to 6.2) indicated
that a severe RNA degradation occurred. In contrast, our RIN
values ranged from 6.0 to 9.1 (mean value 7.4), suggesting
that postmortem in vivo RNA degradation (up to 6 days after
death) might be a minor issue, in particular, when applying
modern molecular biological methodologies such as whole-
genome microarrays and qRT-PCR. A nearly 3-fold higher
postmortem interval (PMI) did not influence the RIN quality
(PMI median, 58 vs. 22 h cited by Koppelkamm and col-
leagues [40]).
We were curious about the impact of age at biosampling,
the survival time, and the differences in the postmortem
interval among our groups. We examined their impact in order
to discriminate between both groups. Fortunately, all three
confounders did not have any significant influence, which is
in line with the low number of differentially expressed genes
found among both groups, indicating close similarities in
transcriptional control irrespective of, e.g., age differences.
Our study has some limitations. In particular, the number of
examined individuals is low. Therefore, the promising con-
cordance, PPV and NPV, should be taken with caution and
definitely have to be validated in another and independent
group. We were curious about the large inter-individual vari-
ance of gene expression data and the impact of environmental
factors not covered by our study design and interfering with
our results. However, the very consistent normalized Ct values
and low standard deviations measured among all group mem-
bers and the low number of differentially expressed genes
argues against a strong impact of these factors on our results.
The high consistency of gene expression measurements per-
formed by whole-genome microarrays and qRT-PCR lessens
concerns that our findings are due to methodological artifacts.
Taken together, our results reveal that cerebral hypoxia
after a frontal cortex injury causes gene expression changes
that can be measured in the cerebellum. The understanding of
these gene regulation mechanisms expands our knowledge
about hypoxia after TBI. Our novel miRNA markers are
useful for postmortem studies where the tissue can be degrad-
ed and other markers failed.
In further studies, it should be analyzed whether the con-
centration of our novel hypoxia markers vary in dependence
of the severity of a brain injury. In this case, the markers could
be used to estimate the severity of a brain injury. Furthermore,
the novel hypoxia markers could be new targets for future
therapies.
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